The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial

BACKGROUND: Patients with liver cirrhosis have a highly elevated risk of developing bacterial infections that significantly decrease survival rates. One of the most relevant infections is spontaneous bacterial peritonitis (SBP). Recently, NOD2 germline variants were found to be potential predictors...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Trials
Главные авторы: Casper, Markus, Mengel, Martin, Fuhrmann, Christine, Herrmann, Eva, Appenrodt, Beate, Schiedermaier, Peter, Reichert, Matthias, Bruns, Tony, Engelmann, Cornelius, Grünhage, Frank, Lammert, Frank
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Study Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359533/
https://ncbi.nlm.nih.gov/pubmed/25887140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0594-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы